First-line chemotherapy plus immunotherapy in biliary tract cancer

被引：3
|
作者：
Neuzillet, Cindy [1 ]
机构：
[1] Paris Saclay Univ, Versailles St Quentin Univ, Curie Inst, Dept Med Oncol, F-92210 St Cloud, France
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 06期
关键词：
D O I：
10.1016/S2468-1253(22)00052-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [21] Nomograms predicting survival of patients with advanced or recurrent biliary tract cancer receiving a first-line chemotherapy
    Takahara, N.
    Nakai, Y.
    Saito, K. O.
    Sato, M.
    Ooyama, H.
    Kanai, S.
    Suzuki, T.
    Sato, T.
    Hakuta, R.
    Ishigaki, K.
    Takeda, T.
    Mizuno, S.
    Kogure, H.
    Tada, M.
    Koike, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Phase II study of gemcitabine and oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Kim, H.
    Lee, S.
    Bae, S.
    Kim, C.
    Lee, N.
    Lee, K.
    Park, S.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Impact of itraconazole after first-line chemotherapy on the survival of patients with distant metastatic biliary tract cancer
    Tsubamoto, Hiroshi
    Sonoda, Takashi
    Inoue, Kayo
    Ikuta, Shinichi
    Tani, Satoshi
    Yamanaka, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients
    Engin, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Nab-paclitaxel plus capecitabine as first-line treatment for patients with recurrence or metastatic biliary tract cancer
    Zhou, J.
    Zong, Y.
    Yuan, J.
    Peng, Z.
    Lu, M.
    Wang, X.
    Shen, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1315 - S1315
  • [26] Biomarker exploration for SHR-1210 plus GEMOX as first-line treatment in advanced biliary tract cancer
    Chen, Xiaofeng
    Wu, Hao
    Wu, Xiaofeng
    Shao, Qianwen
    Zhu, Feipeng
    Qian, Xiaofeng
    Zhao, Fengjiao
    Mao, Weidong
    Sun, Jing
    Wang, Jian
    Han, Gaohua
    Li, Huajun
    Zhu, Dongqin
    Zhu, Liuqing
    Li, Changxian
    Seesaha, Poshita Kumari
    Shao, Yang
    Gu, Yanhong
    Li, Xiangcheng
    Shu, Yongqian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Kim, Hyun Jung
    Lee, Nam Su
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Cheon, Young Gook
    Kim, Young Seok
    Moon, Jong Ho
    Cho, Young Deok
    Park, Sang Heum
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Park, Hee Sook
    Hong, Dae Sik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 371 - 377
  • [28] A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
    Ulusakarya, Ayhan
    Karaboue, Abdoulaye
    Ciacio, Oriana
    Pittau, Gabriella
    Haydar, Mazen
    Biondani, Pamela
    Gumus, Yusuf
    Chebib, Amale
    Almohamad, Wathek
    Innominato, Pasquale F.
    BMC CANCER, 2020, 20 (01)
  • [29] A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Hyun Jung Kim
    Nam Su Lee
    Sang-Cheol Lee
    Sang Byung Bae
    Chan Kyu Kim
    Young Gook Cheon
    Young Seok Kim
    Jong Ho Moon
    Young Deok Cho
    Sang Heum Park
    Kyu Taek Lee
    Sung Kyu Park
    Jong-Ho Won
    Hee Sook Park
    Dae Sik Hong
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 371 - 377
  • [30] Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
    Oh, Do-Youn
    Ikeda, Masafumi
    Lee, Choong-kun
    Rojas, Carlos
    Hsu, Chih-Hung
    Kim, Jin Won
    Shen, Lin
    Furuse, Junji
    Park, Joon Oh
    Borad, Mitesh
    de Braud, Filippo
    Bridgewater, John
    Lee, Sunyoung S.
    Moehler, Markus
    Audhuy, Francois
    Osada, Motonobu
    Sato, Masashi
    Yoo, Changhoon
    HEPATOLOGY, 2025, 81 (03) : 823 - 836
12345